Merrimack Pharmaceuticals, Inc.
MACK
$0.02
Change (1 day)
$15.89
Year High
$11.53
Year Low
Categories
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Earnings for Merrimack Pharmaceuticals, Inc. (MACK)
Earnings in 2023 (TTM): $-1,169,000
According to Merrimack Pharmaceuticals, Inc.'s latest financial reports the company's current earnings (TTM) are $-1,169,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Merrimack Pharmaceuticals, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-1,169,000 | $-1,181,000 |
| 2022 | $-1,541,000 | $-1,544,000 |
| 2021 | $-2,452,000 | $-2,455,000 |
| 2020 | $-3,014,000 | $-3,028,000 |
| 2019 | $-22,740,000 | $-21,267,000 |
| 2018 | $-68,462,000 | $-40,506,000 |
| 2017 | $-118,403,000 | $472.03 M |
| 2016 | $-153,518,000 | $-151,740,000 |
| 2015 | $-147,787,000 | $-147,957,000 |
| 2014 | $-83,559,000 | $-83,291,000 |
| 2013 | $-130,685,000 | $-130,925,000 |
| 2012 | $-91,754,000 | $-91,277,000 |
| 2011 | $-79,676,000 | $-79,223,000 |
| 2010 | $-50,159,000 | $-50,104,000 |
| 2009 | $-52,475,000 | $-49,073,000 |